نتائج البحث - "Isabell Bernlochner"

81

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

المصدر: Schulz-Schüpke, S, Byrne, R A, Ten Berg, J M, Neumann, F-J, Han, Y, Adriaenssens, T, Tölg, R, Seyfarth, M, Maeng, M, Zrenner, B, Jacobshagen, C, Mudra, H, von Hodenberg, E, Wöhrle, J, Angiolillo, D J, von Merzljak, B, Rifatov, N, Kufner, S, Morath, T, Feuchtenberger, A, Ibrahim, T, Janssen, P W A, Valina, C, Li, Y, Desmet, W, Abdel-Wahab, M, Tiroch, K, Hengstenberg, C, Bernlochner, I, Fischer, M, Schunkert, H, Laugwitz, K-L, Schömig, A, Mehilli, J, Kastrati, A & on behalf of the Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) trial investigators 2015, ' ISAR-SAFE : a randomized, double-blind, placebo-controlled trial of 6 versus 12 months of clopidogrel therapy after drug-eluting stenting ', European Heart Journal . https://doi.org/10.1093/eurheartj/ehu523Test

مصطلحات موضوعية: Male, medicine.medical_specialty, Ticlopidine, medicine.medical_treatment, Placebo-controlled study, Myocardial Infarction, Hemorrhage, Coronary Artery Disease, Placebo, Drug Administration Schedule, law.invention, Percutaneous Coronary Intervention, Randomized controlled trial, Double-Blind Method, law, medicine, Clinical endpoint, Humans, cardiovascular diseases, Stroke, Aged, business.industry, Hazard ratio, Graft Occlusion, Vascular, Drug-Eluting Stents, Middle Aged, Clopidogrel, medicine.disease, Surgery, Prosthesis Failure, ddc, Treatment Outcome, Drug-eluting stent, Female, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors, medicine.drug